Migraines affect millions of people worldwide, causing significant disruption to work, school, and daily life. Despite their widespread impact, many people with migraines remain undiagnosed or misdiagnosed for years, which delays effective treatment and compounds the burden on quality of life. Understanding how migraines are diagnosed and what treatment options are available can help you take control of your health and work more effectively with your healthcare provider.
The good news is that migraine diagnosis and treatment have evolved considerably. Today, healthcare professionals use established clinical criteria to identify migraines, and a growing range of treatment options—from well-established medications to newer therapies—can be tailored to your specific needs and circumstances.
Migraines are far more than just severe headaches. A migraine is a brain-network disorder involving sensory processing, pain modulation, trigeminal nerve activation, neuropeptides such as CGRP and PACAP, and, in some patients, cortical spreading depression related to aura. The condition can cause not only intense head pain but also nausea, vomiting, and heightened sensitivity to light and sound.
Symptoms can begin hours to days before pain onset and can persist during pain and following pain resolution. For some people, migraines are occasional; for others, they become chronic and significantly impact functioning.
One important fact to know upfront: "Currently, there's no blood test, biomarker or brain scan that can definitively diagnose migraine." This means that diagnosis relies primarily on your medical history and clinical presentation, not laboratory or imaging tests.
The diagnosis of migraine is based on the history. Your healthcare provider will ask detailed questions to understand your headache pattern. An adequate medical history must include at least the following: age at onset of headache; duration of headache episodes; frequency of headache episodes; pain characteristics (for example, location, quality, severity, aggravating factors and relieving factors); accompanying symptoms (for example, photophobia, phonophobia, nausea and vomiting); aura symptoms (if any); and history of acute and preventive medication use.
The ICHD-3 criteria, which were developed by the International Headache Society, set out the clinical features that establish the diagnosis of migraine and its types and subtypes. Migraine without aura requires at least five attacks lasting 4–72 hours (when untreated or unsuccessfully treated), with at least two of the following four characteristics: unilateral location, pulsating quality, moderate or severe pain intensity, or aggravation by or causing avoidance of routine physical activity (e.g., walking or climbing stairs). Additionally, during headache at least one of the following is present: nausea and/or vomiting, or photophobia and phonophobia.
The International Headache Society defines aura as reversible focal neurologic symptoms that usually develop gradually over 5–20 minutes and last for less than 60 minutes. Some people experience migraine with aura (often visual disturbances), while others have migraine without aura.
Although a thorough screening neurologic examination is essential, the results will be normal in most patients with headache. The neurological exam helps rule out other conditions that might cause similar symptoms and ensures that no concerning findings are present.
Patients are encouraged to keep a headache journal to help identify factors that may be contributing to the attacks, recording when headaches occur, how severe they are, what treatments you used and whether there were possible triggers, such as stress, dehydration, poor sleep, foods eaten or environmental factors. This information can help patients and healthcare providers determine which treatments are working and what lifestyle factors may be contributing to migraine frequency.
Migraine treatment falls into two distinct categories, each serving a different purpose. It is important to understand the difference between these approaches, as using the wrong type can lead to disappointment and wasted time.
| Treatment Type | Purpose | When It Is Used | Goal |
|---|---|---|---|
| Acute (Abortive) | Stop a migraine attack in progress | At the first sign of a migraine | Relieve pain and associated symptoms quickly |
| Preventive (Prophylactic) | Reduce future attacks | Taken daily, regardless of symptoms | Reduce frequency, severity, and duration of future attacks |
Preventive therapy is generally considered when migraines occur four or more times per month, last longer than 12 hours, or consistently fail to respond to acute treatments. Many patients need both types.
Acute medications are designed to stop a migraine attack once it has started. When it comes to acute migraine treatment, triptans are the most evidence-backed class available. Triptans work by narrowing blood vessels and blocking pain pathways in the brain.
In addition to triptans, newer options have become available. Zavegepant nasal spray is an acute CGRP receptor antagonist option for adults with migraine, useful when nausea, vomiting, or delayed stomach absorption makes oral medication difficult. Nasal or other non-oral formulations can be particularly helpful when stomach upset accompanies the migraine.
Over-the-counter pain relievers like ibuprofen or aspirin may help some people, though they are often less effective than prescription medications for moderate to severe migraines. The choice of acute medication depends on your medical history, the severity of your migraines, and how well you respond to different options.
Preventive medications work to reduce how often and how severely migraines occur. Several classes of medications can be used preventively, each with a different mechanism of action.
Certain blood pressure medications, antidepressants, and anti-seizure drugs have been used successfully for migraine prevention for decades. These medications help stabilize brain activity and reduce the likelihood of migraines occurring. Your healthcare provider will consider your other health conditions when selecting a preventive medication, as some options work particularly well for people with related conditions like high blood pressure or depression.
Advanced treatments include fourth-generation CGRP inhibitors and personalized neurostimulation devices, which promise better outcomes with fewer side effects than traditional approaches. CGRP (calcitonin gene-related peptide) is a molecule involved in migraine pain signaling, and blocking it can significantly reduce migraine frequency.
CGRP-targeted therapies come in different forms. Some are taken by mouth, while others are injections. Rimegepant is approved for both acute migraine treatment and preventive treatment of episodic migraine. Atogepant is approved for preventive treatment of migraine in adults, including chronic migraine.
Research continues to expand the options available. The next pipeline target beyond CGRP is PACAP. In February 2026, Lundbeck announced that IV bocunebart, an investigational anti-PACAP monoclonal antibody, met the primary endpoint in a Phase IIb migraine prevention trial in patients with prior preventive treatment failures. This remains investigational, but it is one of the most important "beyond CGRP" migraine developments to watch.
Researchers are also working to better define migraine subtypes and to personalize treatment. This includes studying biomarkers (measurable signals in blood, imaging, or physiology) that might predict which treatment will work best. Personalized approaches to choosing the right medication for each person are an active area of development.
Your healthcare provider considers many factors when recommending a treatment plan. Your age, other medical conditions, medications you are currently taking, pregnancy status, and past response to treatments all play a role. Improved safety profiles of newer treatments make them suitable for patients with cardiovascular conditions who couldn't tolerate previous options.
Individuals with comorbid conditions like depression or anxiety may benefit from integrated treatment approaches that address both neurological and psychiatric symptoms simultaneously through targeted neurotransmitter modulation. This personalized approach increases the likelihood of finding an effective treatment that works for your specific situation.
Finding the right migraine treatment often takes time and patience. Some people respond extremely well and may have few or no attacks for long stretches while on treatment or after lifestyle changes. However, because migraine patterns can change with age, hormones, stress, sleep, other medical conditions, and medication use, it is difficult to promise a permanent "cure."
When migraine improves substantially, it is usually described as remission or long-term control rather than cure. This means that even highly successful treatment focuses on managing the condition to minimize its impact on your life, rather than eliminating it permanently in most cases.
Migraine diagnosis and treatment have come a long way, and the options available today offer real hope for better control and quality of life. Talk with a qualified healthcare professional about your symptoms and concerns. Together, you can develop a personalized treatment plan that works for you and helps you reclaim your life from the burden of migraines.